Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2010

Open Access 01-04-2010 | Meeting abstract

Use of methylphenidate in the treatment of major depressive disorder in an outpatient mental health center

Authors: Carolina Garnier Lacueva, Juan Castaño, Patricia Alvaro, Rosa Sanchis, David Córcoles, Francisco Portillo, Belen Diaz, Luis Miguel Martin, Antoni Bulbena

Published in: Annals of General Psychiatry | Special Issue 1/2010

Login to get access

Excerpt

According to the American Psychiatric Association practice guidelines, if a patient with Major Depressive Disorder (MDD) has not responded or achieved only a partial response after 4-8 weeks of therapy, a dose change, switch to a new drug, or augmentation therapy is recommended [1]. …
Literature
1.
American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000, American Psychiatric Association, 157: 1-45.
2.
Lavretsky Helen, Park Susan, Siddarth Prabha, Kumar Anand, Reynolds Charles: Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial. Am J Geriatr Psychiatry. 2006, 14: 2-10.1097/01.JGP.0000192503.10692.9f.CrossRef
3.
Craig Nelson J, Pikalov A, Berman R: Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatri Dis Treat San Francisco. 2008, 4 (5): 937-948.
Metadata
Title
Use of methylphenidate in the treatment of major depressive disorder in an outpatient mental health center
Authors
Carolina Garnier Lacueva
Juan Castaño
Patricia Alvaro
Rosa Sanchis
David Córcoles
Francisco Portillo
Belen Diaz
Luis Miguel Martin
Antoni Bulbena
Publication date
01-04-2010
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue Special Issue 1/2010
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-9-S1-S167

Other articles of this Special Issue 1/2010

Annals of General Psychiatry 1/2010 Go to the issue

Meeting abstract

Cross-cultural psychopharmacology: a review

Meeting abstract

Chronic pain and substance use in patients with Hepatitis C

Meeting abstract

Panic disorder as presenting symptoms of multiple sclerosis

Meeting abstract

The Test of Word Finding (TWF - 2). (A pilot study and validation of the test in normal Greek population aged from 5 years till 5 years and 11 months)

Meeting abstract

Guidelines for research: requirements and challenges

Meeting abstract

Alcohol-related glucose-dependent functional system of error processing